Oral Presentation 6th Annual Scientific Meeting of the Australian and New Zealand Society for Sarcopenia and Frailty Research 2024

Associations between sleep and breathing with sarcopenia in postmenopausal women (#18)

Rajani Khanal 1 , Kelly Sansom 1 2 , Kimberley van Schooten 3 4 , Ronaldo Piovezan 5 6 , Robert Adams 1 , Barbara Toson 1 , Pedro Marques-Vidal 7 , Raphael Heinzer 8 , Olivier Lamy 9 , Didier Hans 9 , Hose Haba-Rubio 8 , Andrew Vakulin 1
  1. Flinders Health and Medical Research Institute, Sleep Health, Flinders University, Adelaide, South Australia, Australia
  2. Centre for Healthy Ageing, Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia
  3. Falls, Balance and Injury Research Centre, Neuroscience Research Australia, Sydney, New South Wales, Australia
  4. School of Population Health, Univesity of New South Wales, Sydney, New South Wales, Australia
  5. Adelaide Geriatrics Training and Research with Aged Care (GTRAC) Centre, University of Adelaide, Adelaide, South Australia, Australia
  6. Aged and Extended Care Services, The Queen Elizabeth Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia
  7. Internal Medicine Department, CHUV, Lousanne, Switzerland
  8. Center for Investigation and Research in Sleep, Pulmonary Department, University Hospital of Lausanne, Lousanne, Switzerland
  9. Center for Bone Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

Associations between sleep and breathing with sarcopenia in postmenopausal women.

Background

Post-menopausal women are at increased risk of sleep disturbance and sarcopenia [1, 2]. Emerging evidence indicates that reduced muscle mass and muscle strength may be influenced by disturbed sleep via a complex interplay of hormonal, metabolic and inflammatory pathways alongside a lack of physical activity [3]. We aimed to investigate the cross-sectional associations between sleep and breathing with sarcopenia in postmenopausal women.

Methods:

The study focused on female participants [median age (interquartile range): 59 (54-67) years, N=389] from the 1st follow-up of the Colaus study [4, 5]who underwent polysomnography (PSG) examinations and dual-energy X-ray absorptiometry (DXA). Sarcopenia was defined according to the Foundation for the National Institutes of Health criteria: low muscle mass and low muscle strength [6]. Appendicular skeletal muscle mass adjusted for body mass index (ASMI) was used as a measure of muscle mass, and handgrip strength was used as a measure of muscle strength. Participants were categorised as having sarcopenia when their ASMI and handgrip strength both fell within the lowest tertile of the sample distribution (cut off values 0.64 and 22.38kg respectively). Indicators of sleep disturbance were defined as short sleep duration (<6 hours), poor sleep efficiency (<80%), prolonged sleep onset latency (>30 minutes), time in slow wave sleep and rapid eye movement sleep below median, prolonged wake after sleep onset (WASO) (awake for >30 minutes), and obstructive sleep apnoea (OSA) severity as indicated by apnoea hypopnea index (AHI)  (number of events /hour) and nocturnal hypoxemia (>1% of sleep time with oxygen saturation below 90%). Confounders tested for inclusion were age, smoking, alcohol consumption, weekly energy consumption and comorbidities. Binomial logistic regression models analyzed associations between sleep and breathing with sarcopenia.

Results:

Sarcopenia was detected in 61(15.7%) of the participants. After adjustment for potential confounders, short sleep duration (Odds ratio [OR]=1.10, 95% Confidence interval [CI] = 1.01-1.21), prolonged WASO (OR=1.09, 95% CI= 1.01-1.17), severe OSA (AHI> 30) (OR=1.21, 95% CI= 1.06-1.38) and nocturnal hypoxemia (OR=1.09, 95% CI= 1.01-1.19) were significantly associated with sarcopenia.

Conclusion:

Postmenopausal women experiencing sleep and breathing disturbance including short sleep duration, increased night-time wakefulness and severe OSA are more likely to have sarcopenia. The potential pathophysiological links between sleep disturbance and sarcopenia create future opportunities to develop interventions and public policies to reduce the burden derived from age-related conditions.

 

  1. 1. Jehan, S., et al., Sleep disorders in postmenopausal women. Journal of sleep disorders & therapy, 2015. 4(5).
  2. 2. Anagnostis, P., et al., Sarcopenia in post-menopausal women: Is there any role for vitamin D? Maturitas, 2015. 82(1): p. 56-64.
  3. 3. Piovezan, R.D., et al., The impact of sleep on age-related sarcopenia: Possible connections and clinical implications. Ageing research reviews, 2015. 23: p. 210-220.
  4. 4. Marques-Vidal, P., et al., Assessing the associations between mental disorders, cardiovascular risk factors, and cardiovascular disease: the CoLaus/PsyCoLaus study. 2011, Lausanne: Institut universitaire de médecine sociale et préventive (IUMSP).
  5. 5. Firmann, M., et al., The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord, 2008. 8: p. 6.
  6. 6. Studenski, S.A., et al., The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci, 2014. 69(5): p. 547-58.